DGX
Price
$176.03
Change
+$2.45 (+1.41%)
Updated
Apr 24, 04:59 PM (EDT)
Capitalization
14.74B
90 days until earnings call
TMO
Price
$426.82
Change
-$4.82 (-1.12%)
Updated
Apr 24, 04:59 PM (EDT)
Capitalization
220.19B
90 days until earnings call
Ad is loading...

DGX vs TMO

Header iconDGX vs TMO Comparison
Open Charts DGX vs TMOBanner chart's image
Quest Diagnostics
Price$176.03
Change+$2.45 (+1.41%)
Volume$18.45K
Capitalization14.74B
Thermo Fisher Scientific
Price$426.82
Change-$4.82 (-1.12%)
Volume$14.7K
Capitalization220.19B
DGX vs TMO Comparison Chart
Loading...
DGX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TMO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DGX vs. TMO commentary
Apr 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DGX is a Buy and TMO is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 24, 2025
Stock price -- (DGX: $173.57 vs. TMO: $431.64)
Brand notoriety: DGX and TMO are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: DGX: 133% vs. TMO: 160%
Market capitalization -- DGX: $14.74B vs. TMO: $220.19B
DGX [@Medical Specialties] is valued at $14.74B. TMO’s [@Medical Specialties] market capitalization is $220.19B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.31B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DGX’s FA Score shows that 4 FA rating(s) are green whileTMO’s FA Score has 0 green FA rating(s).

  • DGX’s FA Score: 4 green, 1 red.
  • TMO’s FA Score: 0 green, 5 red.
According to our system of comparison, DGX is a better buy in the long-term than TMO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DGX’s TA Score shows that 5 TA indicator(s) are bullish while TMO’s TA Score has 6 bullish TA indicator(s).

  • DGX’s TA Score: 5 bullish, 4 bearish.
  • TMO’s TA Score: 6 bullish, 2 bearish.
According to our system of comparison, TMO is a better buy in the short-term than DGX.

Price Growth

DGX (@Medical Specialties) experienced а +5.53% price change this week, while TMO (@Medical Specialties) price change was -1.18% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +4.08%. For the same industry, the average monthly price growth was -6.75%, and the average quarterly price growth was -2.65%.

Reported Earning Dates

DGX is expected to report earnings on Jul 23, 2025.

TMO is expected to report earnings on Jul 23, 2025.

Industries' Descriptions

@Medical Specialties (+4.08% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TMO($220B) has a higher market cap than DGX($14.7B). TMO has higher P/E ratio than DGX: TMO (37.38) vs DGX (17.99). DGX YTD gains are higher at: 16.183 vs. TMO (-16.959). TMO has higher annual earnings (EBITDA): 11.1B vs. DGX (1.73B). TMO has more cash in the bank: 8.08B vs. DGX (686M). DGX has less debt than TMO: DGX (5.5B) vs TMO (34.9B). TMO has higher revenues than DGX: TMO (42.9B) vs DGX (9.25B).
DGXTMODGX / TMO
Capitalization14.7B220B7%
EBITDA1.73B11.1B16%
Gain YTD16.183-16.959-95%
P/E Ratio17.9937.3848%
Revenue9.25B42.9B22%
Total Cash686M8.08B8%
Total Debt5.5B34.9B16%
FUNDAMENTALS RATINGS
DGX vs TMO: Fundamental Ratings
DGX
TMO
OUTLOOK RATING
1..100
7752
VALUATION
overvalued / fair valued / undervalued
1..100
10
Undervalued
64
Fair valued
PROFIT vs RISK RATING
1..100
1350
SMR RATING
1..100
5959
PRICE GROWTH RATING
1..100
2564
P/E GROWTH RATING
1..100
2082
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

DGX's Valuation (10) in the Servicestothe Health Industry industry is somewhat better than the same rating for TMO (64) in the Medical Specialties industry. This means that DGX’s stock grew somewhat faster than TMO’s over the last 12 months.

DGX's Profit vs Risk Rating (13) in the Servicestothe Health Industry industry is somewhat better than the same rating for TMO (50) in the Medical Specialties industry. This means that DGX’s stock grew somewhat faster than TMO’s over the last 12 months.

DGX's SMR Rating (59) in the Servicestothe Health Industry industry is in the same range as TMO (59) in the Medical Specialties industry. This means that DGX’s stock grew similarly to TMO’s over the last 12 months.

DGX's Price Growth Rating (25) in the Servicestothe Health Industry industry is somewhat better than the same rating for TMO (64) in the Medical Specialties industry. This means that DGX’s stock grew somewhat faster than TMO’s over the last 12 months.

DGX's P/E Growth Rating (20) in the Servicestothe Health Industry industry is somewhat better than the same rating for TMO (82) in the Medical Specialties industry. This means that DGX’s stock grew somewhat faster than TMO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
DGXTMO
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
58%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
71%
Bullish Trend 2 days ago
67%
Momentum
ODDS (%)
Bullish Trend 2 days ago
71%
Bullish Trend 2 days ago
67%
MACD
ODDS (%)
Bullish Trend 2 days ago
65%
Bullish Trend 2 days ago
64%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
65%
Bearish Trend 2 days ago
56%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
62%
Bearish Trend 2 days ago
61%
Advances
ODDS (%)
Bullish Trend 2 days ago
65%
Bullish Trend 11 days ago
61%
Declines
ODDS (%)
Bearish Trend 4 days ago
47%
Bearish Trend 4 days ago
61%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
54%
Bullish Trend 2 days ago
54%
Aroon
ODDS (%)
Bearish Trend 2 days ago
35%
Bearish Trend 2 days ago
53%
View a ticker or compare two or three
Ad is loading...
DGX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TMO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
USEG1.110.02
+1.38%
US Energy Corp
NRDS8.810.11
+1.26%
NerdWallet
ABEV2.450.02
+0.82%
Ambev SA
TKC6.150.03
+0.49%
Turkcell Iletisim Hizmetleri AS
MNPR41.94-1.02
-2.37%
Monopar Therapeutics Inc

DGX and

Correlation & Price change

A.I.dvisor indicates that over the last year, DGX has been closely correlated with LH. These tickers have moved in lockstep 66% of the time. This A.I.-generated data suggests there is a high statistical probability that if DGX jumps, then LH could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DGX
1D Price
Change %
DGX100%
+0.42%
LH - DGX
66%
Closely correlated
+1.77%
TMO - DGX
44%
Loosely correlated
-0.71%
HOLX - DGX
43%
Loosely correlated
-0.07%
ABT - DGX
40%
Loosely correlated
-1.43%
SYK - DGX
40%
Loosely correlated
+2.58%
More

TMO and

Correlation & Price change

A.I.dvisor indicates that over the last year, TMO has been closely correlated with A. These tickers have moved in lockstep 79% of the time. This A.I.-generated data suggests there is a high statistical probability that if TMO jumps, then A could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TMO
1D Price
Change %
TMO100%
-0.71%
A - TMO
79%
Closely correlated
+2.13%
DHR - TMO
77%
Closely correlated
+2.21%
WAT - TMO
76%
Closely correlated
+1.25%
RVTY - TMO
70%
Closely correlated
+1.46%
IQV - TMO
67%
Closely correlated
+2.40%
More